Navigation Links
Bayer's Novel Anti-Cancer Compound Regorafenib (BAY 73-4506) Showed Stabilization or Regression in 81 Percent of Kidney Cancer Patients
Date:9/22/2009

revent the proliferation of tumor cell lines while promoting apoptosis (cell death) by directly targeting several oncogenic TK receptors. The clinical significance of these studies is not known and warrant further investigation in a broad spectrum of tumors.

About Bayer HealthCare Pharmaceuticals Inc.

Bayer HealthCare Pharmaceuticals Inc. is the U.S.-based pharmaceuticals unit of Bayer HealthCare LLC, a subsidiary of Bayer Corporation. One of the world's leading, innovative companies in the healthcare and medical products industry, Bayer HealthCare combines the global activities of the Animal Health, Consumer Care, Diabetes Care, and Pharmaceuticals divisions. In the U.S., Bayer HealthCare Pharmaceuticals comprises the following business units: Diagnostic Imaging, General Medicine, Specialty Medicine and Women's Healthcare. The company's aim is to provide products that will improve human health worldwide by diagnosing, preventing and treating diseases.

Details on the studies and the abstract #7105 can be found on the ECCO 15 - 34th ESMO website: http://www.ecco-org.eu/Conferences-and-Events/ECCO-15/page.aspx/216.

Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever t
'/>"/>

SOURCE Bayer HealthCare
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Novel Technology Breaks Through Cancer Pain
2. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
3. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
4. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
5. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
6. The Lancet Publishes Major Phase 3 Study on Novel Oral Direct Thrombin Inhibitor
7. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
8. Phase 2 Clinical Studies Initiated for a Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration
9. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
10. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
11. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... -- Unilife Corporation (NASDAQ: UNIS, ASX: UNS), a designer, manufacturer ... that its Chairman and CEO, Alan Shortall , ... Annual Healthcare Conference at the New York Palace Hotel ... The conference presentation will be broadcast ... To listen, please go to: http://ir.unilife.com/events.cfm . An ...
(Date:11/26/2014)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) today ... two upcoming investor conferences.  , 31 st ... Tuesday, December 2, 2014 at 6:45 a.m. EST / 11:45 a.m. ... EUSA International, will provide an overview of the company and a ... Jaffray Healthcare Conference in New York, NY ...
(Date:11/26/2014)... Nepstar Chain Drugstore Ltd. (NYSE: NPD ) ("Nepstar" ... China based on the number of directly operated stores, ... quarter ended September 30, 2014. Financial HighlightsFor the ... increased by 8.1% compared to the third quarter of ... million (US$120.3 million) compared to RMB683.2 million in the third ...
Breaking Medicine Technology:Unilife to Present at the Piper Jaffray 26th Annual Healthcare Conference on December 2nd 2Jazz Pharmaceuticals Announces Participation in Two Investor Conferences 2China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 2China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 3China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 4China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 5China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 6China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 7China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 8China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 9China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 10China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 11
... , PALO ALTO, Calif., Oct. 14 Jazz Pharmaceuticals, Inc. ... company,s first Phase III clinical trial of sodium oxybate (JZP-6) ... during the American College of Rheumatology 2009 Annual Meeting (ACR) ... Psychiatric and Mental Health Congress (US Psych Congress) in Las ...
... Oct. 14 Pelleve(TM), a skin tightening system for ... 120 million homes across the country this weekend on ... brings consumers the latest in beauty innovation and education. ... Spaces," "Beauty Spaces" interviewed Dr. Michael Stampar to learn ...
Cached Medicine Technology:Data from Jazz Pharmaceuticals' First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia to be Presented at Upcoming Conferences 2Data from Jazz Pharmaceuticals' First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia to be Presented at Upcoming Conferences 3Pelleve(TM) Wrinkle Treatment System Featured On 'Beauty Spaces' TV Show 2
(Date:11/26/2014)... Anthropologists have identified concrete recommendations that ... Ebola, improve international support, and pave the way ... Africa. , The report, “Strengthening West African ... Insights,” will be made public during a press ... Fri., Dec. 5, 11 a.m., at the AAA ...
(Date:11/26/2014)... CA (PRWEB) November 26, 2014 Bunion ... offering lower prices in an early celebration of the ... Booties are being offered at the promotional price of ... pricing is in addition to any automatic discounts applied ... Bunion Bootie website for complete details. It’s ...
(Date:11/26/2014)... 26, 2014 News Facts , ... capabilities at RSNA 2014 in Chicago. The company ... share diagnostic images, photos, videos and documents found ... #8107 will learn more about these innovative medical ... and partner initiatives – that enable more informed ...
(Date:11/26/2014)... TUESDAY, Nov. 25, 2014 (HealthDay News) -- Youngsters who ... a new study suggests. Early puberty was linked ... as poor self-image and high anxiety levels, according to ... problems, such as conflict with family and peers, and ... the study found. Although the study found an ...
(Date:11/26/2014)... TUESDAY, Nov. 25, 2014 (HealthDay News) -- The number of ... 130 million in 2010 to a record 136 million in ... Prevention. The findings also showed that fewer people were ... patients were identified as needing medical care within two hours ... 92 percent, according to the research. Sixty percent of ...
Breaking Medicine News(10 mins):Health News:Anthropologists Release Recommendations, Better Practices to Contain Ebola 2Health News:Anthropologists Release Recommendations, Better Practices to Contain Ebola 3Health News:Bunion Bootie Temporarily Lowering Prices for Holiday Shopping, Starting Today! 2Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 2Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 3Health News:Early Puberty Linked to Increased Risk of Depression in Teens 2Health News:ER Visits on the Rise, Study Reports 2
... MEXICO CITY, July 31 As thousands gather ... August 3-8, 2008,Catholics for Choice and its Latin ... will be highlighting Catholic opposition to the,Vatican,s ban ... http://www.Condoms4Life.org ., From the opening moments ...
... July 31 /PRNewswire-FirstCall/ - CRH Medical Corporation,(CRM:TSX-V) announced today ... Arlington Virginia. This Center is the Company,s first center ... that CRH has targeted for,expansion. The opening of this ... the Company,s total number of Centers to 17., ...
... Sound Public Policies Needed, WASHINGTON, July 31 ... with the convening of the,International AIDS Conference in Mexico ... is anticipated to announce on August 3rd,significantly higher HIV ... 40,000 new infections per year; the new number may ...
... an increased risk of developing cardiovascular disease, particularly stroke ... Atherosclerosis , has now led to attempts to ... (hardening of the arteries) is an inflammatory disease in ... and become less elastic. It can cause blood clots ...
... Educational and media,outreach efforts by The Soap ... the health benefits of hand hygiene have been,honored ... Excellence., The honor is given annually by ... that "propel America forward with,innovative projects in education, ...
... Tenn., July 31 HCA today announced financial,and operating results for ... Summary:, -- Revenues increased 3.7 percent to $6.980 billion. ... the prior year,s second quarter. -- ... the second quarter of 2007. -- Salaries ...
Cached Medicine News:Health News:Catholics at International AIDS Conference XVII Tell Pope: End Ban on Condoms 2Health News:CRH Medical Corporation opens center in Virginia 2Health News:Higher Number of HIV Infections Must Translate Into Leadership & Action by U.S. Government 2Health News:New discovery may lead to immunization against cardiovascular disease 2Health News:SDA Hygiene Outreach Efforts Honored with Award of Excellence 2Health News:SDA Hygiene Outreach Efforts Honored with Award of Excellence 3Health News:HCA Reports Second Quarter 2008 Results 2Health News:HCA Reports Second Quarter 2008 Results 3Health News:HCA Reports Second Quarter 2008 Results 4Health News:HCA Reports Second Quarter 2008 Results 5Health News:HCA Reports Second Quarter 2008 Results 6Health News:HCA Reports Second Quarter 2008 Results 7Health News:HCA Reports Second Quarter 2008 Results 8Health News:HCA Reports Second Quarter 2008 Results 9Health News:HCA Reports Second Quarter 2008 Results 10Health News:HCA Reports Second Quarter 2008 Results 11Health News:HCA Reports Second Quarter 2008 Results 12Health News:HCA Reports Second Quarter 2008 Results 13Health News:HCA Reports Second Quarter 2008 Results 14
The new Shandon HistocentreTM 3 is an integral part of the workflow in Histology laboratories, representing a workstation that complements any automatic tissue processor....
... The Netmon remote monitoring service ... be programmed and monitored from any ... The service enhances preventive maintenance ... may access the unit (with your ...
... a service that directly connects the ... customers laboratory to the Thermo Electron ... and Runcorn, U.K.* By using a ... site, high-value support services are made ...
The Shandon Citadel is a low cost, reliable, time-tested carousel-type tissue processor with convenient touch key operation. The Citadel 2000 has 110 cassette capacity and the Citadel 1000 has a cap...
Medicine Products: